Ingevity Corp (FRA:IGX)
€ 42.32 -0.22 (-0.52%) Market Cap: 1.52 Bil Enterprise Value: 2.84 Bil PE Ratio: 0 PB Ratio: 7.67 GF Score: 74/100

Q2 2024 Ingevity Corp Earnings Call Transcript

Aug 01, 2024 / 03:00PM GMT
Release Date Price: €40.18 (-5.33%)

Key Points

Positve
  • Performance Materials delivered a fourth straight quarter of 50%-plus EBITDA margins.
  • Advanced Polymer Technologies saw a third straight quarter of volume growth.
  • Operational efficiencies in Performance Materials led to lower energy usage and cost savings.
  • Termination of the CTO supply contract is expected to improve profitability in the Performance Chemicals segment.
  • Consolidated EBITDA margins improved by 80 basis points to 26%.
Negative
  • Second-quarter sales were down 19% due to repositioning actions in Performance Chemicals and adverse weather conditions.
  • Performance Chemicals segment experienced a 35% decline in sales and a 79% drop in EBITDA.
  • A non-cash goodwill impairment charge of $349 million was recorded for the Performance Chemicals segment.
  • Free cash flow guidance for the full year was revised from $75 million to slightly positive due to the $100 million CTO contract termination fee.
  • Industrial market recovery remains weaker than anticipated, impacting revenue growth.
Operator

Good morning all and thank you all for attending the Ingevity second-quarter 2024 earnings call and webcast. My name is Brika, and I will be your moderator today. (Operator instructions)

I would now like to pass the conference over to your host, John Nypaver from Ingevity to begin. So you may proceed, John.

John Nypaver
Ingevity Corp - Vice President - Treasurer and Investor Relations

Thank you, Brika. Good morning and welcome to Ingevity's second-quarter 2024 earnings call. Earlier this morning, we posted a presentation on our investor site that you can use to follow today's discussion. It can be found on ir.ingevity.com under Events and Presentations. Also throughout this call, we may refer to non-GAAP financial measures, which are intended to supplement, not substitute for comparable GAAP measures. Definitions of these non-GAAP financial measures and reconciliations to comparable GAAP measures are included in our earnings release and are also in our most recent Form 10-K.

We may also make forward-looking statements regarding future events

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot